Younger AML. OS comparisons between the (A) ts-AML and non–ts-AML population, (B) various prognostic risk groups including ts-AML, (C) ts-AML and t-AML, and (D) ts-AML based on whether patients had undergone transplant. chr, chromosome; SCT, allogeneic stem cell transplant; tot, total.